35127716|t|Sevoflurane Aggravates the Progress of Alzheimer's Disease Through NLRP3/Caspase-1/Gasdermin D Pathway.
35127716|a|Background: Alzheimer's disease (AD) is the most common form of dementia worldwide. Previous studies have reported that sevoflurane, a frequently used anesthetic, can induce cognitive impairment in preclinical and clinical settings. However, the mechanism underlying the development of this neurotoxicity is currently unclear. Methods: Seven-month-old APP/PS1 mice were placed in an anesthesia induction box containing 3% sevoflurane in 100% O2 for 6 h, while BV2 cells were cultured with 4% sevoflurane for 6 h. Pyroptosis and tau protein expression in excised hippocampus tissues and cells were measured using Western blotting and immunofluorescence assay. Caspase-1 and NLRP3 were knocked out in BV2 microglia using CRISPR/Cas9 technology to determine whether they mediate the effects induced by sevoflurane. Results: Sevoflurane directly activated caspase-1 to induce pyroptosis in the mouse model of AD via NLRP3 and AIM2 activation. In addition, sevoflurane mediated cleavage of gasdermin D (GSDMD) but not gasdermin E (GSDME), promoted the biosynthesis of downstream interleukin-1beta and interleukin-18, and increased beta-amyloid (Abeta) deposition and tau phosphorylation. The nontoxic caspase-1 small-molecule inhibitor VX-765 significantly inhibited this activation process in microglia, while NLRP3 deletion suppressed sevoflurane-induced caspase-1 cleavage and subsequently pyroptosis, as well as tau pathology. Furthermore, silencing caspase-1 alleviated the sevoflurane-induced release of IL-1beta and IL-18 and inhibited tau-related enzymes in microglia. Conclusion: This study is the first to report that clinical doses of sevoflurane aggravate the progression of AD via the NLRP3/caspase-1/GSDMD axis. Collectively, our findings elucidate the crucial mechanisms of NLRP3/caspase-1 in pyroptosis and tau pathogenesis induced by sevoflurane and suggest that VX-765 could represent a novel therapeutic intervention for treating AD.
35127716	0	11	Sevoflurane	Chemical	MESH:D000077149
35127716	39	58	Alzheimer's Disease	Disease	MESH:D000544
35127716	67	72	NLRP3	Gene	216799
35127716	73	82	Caspase-1	Gene	12362
35127716	83	94	Gasdermin D	Gene	69146
35127716	116	135	Alzheimer's disease	Disease	MESH:D000544
35127716	137	139	AD	Disease	MESH:D000544
35127716	168	176	dementia	Disease	MESH:D003704
35127716	224	235	sevoflurane	Chemical	MESH:D000077149
35127716	278	298	cognitive impairment	Disease	MESH:D003072
35127716	395	408	neurotoxicity	Disease	MESH:D020258
35127716	460	463	PS1	Gene	19164
35127716	464	468	mice	Species	10090
35127716	526	537	sevoflurane	Chemical	MESH:D000077149
35127716	546	548	O2	Chemical	-
35127716	564	567	BV2	CellLine	CVCL:0182
35127716	596	607	sevoflurane	Chemical	MESH:D000077149
35127716	617	627	Pyroptosis	Disease	
35127716	763	772	Caspase-1	Gene	12362
35127716	777	782	NLRP3	Gene	216799
35127716	803	806	BV2	CellLine	CVCL:0182
35127716	903	914	sevoflurane	Chemical	MESH:D000077149
35127716	925	936	Sevoflurane	Chemical	MESH:D000077149
35127716	956	965	caspase-1	Gene	12362
35127716	976	986	pyroptosis	Disease	
35127716	994	999	mouse	Species	10090
35127716	1009	1011	AD	Disease	MESH:D000544
35127716	1016	1021	NLRP3	Gene	216799
35127716	1026	1030	AIM2	Gene	383619
35127716	1056	1067	sevoflurane	Chemical	MESH:D000077149
35127716	1089	1100	gasdermin D	Gene	69146
35127716	1102	1107	GSDMD	Gene	69146
35127716	1178	1195	interleukin-1beta	Gene	16176
35127716	1200	1214	interleukin-18	Gene	16173
35127716	1244	1249	Abeta	Gene	11820
35127716	1300	1309	caspase-1	Gene	12362
35127716	1335	1341	VX-765	Chemical	MESH:C520022
35127716	1410	1415	NLRP3	Gene	216799
35127716	1436	1447	sevoflurane	Chemical	MESH:D000077149
35127716	1456	1465	caspase-1	Gene	12362
35127716	1492	1502	pyroptosis	Disease	
35127716	1553	1562	caspase-1	Gene	12362
35127716	1578	1589	sevoflurane	Chemical	MESH:D000077149
35127716	1609	1617	IL-1beta	Gene	16176
35127716	1622	1627	IL-18	Gene	16173
35127716	1745	1756	sevoflurane	Chemical	MESH:D000077149
35127716	1786	1788	AD	Disease	MESH:D000544
35127716	1797	1802	NLRP3	Gene	216799
35127716	1803	1812	caspase-1	Gene	12362
35127716	1813	1818	GSDMD	Gene	69146
35127716	1888	1893	NLRP3	Gene	216799
35127716	1894	1903	caspase-1	Gene	12362
35127716	1907	1917	pyroptosis	Disease	
35127716	1950	1961	sevoflurane	Chemical	MESH:D000077149
35127716	1979	1985	VX-765	Chemical	MESH:C520022
35127716	2048	2050	AD	Disease	MESH:D000544
35127716	Negative_Correlation	MESH:C520022	MESH:D000544
35127716	Positive_Correlation	16176	69146
35127716	Association	MESH:D000544	216799
35127716	Association	MESH:D000544	12362
35127716	Positive_Correlation	MESH:D000077149	MESH:D000544
35127716	Association	MESH:D000077149	216799
35127716	Positive_Correlation	MESH:D000077149	383619
35127716	Positive_Correlation	MESH:D000077149	11820
35127716	Positive_Correlation	MESH:D000077149	12362
35127716	Positive_Correlation	MESH:D000077149	16173
35127716	Association	216799	69146
35127716	Positive_Correlation	16173	69146
35127716	Positive_Correlation	12362	16173
35127716	Association	12362	216799
35127716	Association	MESH:D000544	69146
35127716	Positive_Correlation	MESH:D000077149	16176
35127716	Association	12362	69146
35127716	Positive_Correlation	12362	383619
35127716	Association	MESH:D000077149	69146
35127716	Negative_Correlation	MESH:C520022	12362
35127716	Association	MESH:D000544	383619
35127716	Positive_Correlation	12362	16176
35127716	Positive_Correlation	MESH:D000077149	MESH:D003072

